-+ 0.00%
-+ 0.00%
-+ 0.00%

ENGENE THERAPEUTICS - ESTIMATES $5.7-$6.4 MLN RESTRUCTURING COSTS AND $4.7-$5 MLN NON-CASH STOCK COMPENSATION - SEC FILING

Reuters·06/15/2026 13:17:39

Please log in to view news